U.S. Research Environment Lures Canadian Scientists...

Last summer Huntington Willard, an associate professor of medical genetics at the University of Toronto, surprised a news conference at the 16th International Congress on Genetics by announcing that he was leaving Canada to join the Department of Genetics and the Beckman Center for Molecular and Genetic Medicine headed by Paul Berg at Stanford University. He gave as his reason a lack of resources for basic research at his university and in Canada generally, and the low priority assigned to it.

Written byLouis Siminovitch
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Last summer Huntington Willard, an associate professor of medical genetics at the University of Toronto, surprised a news conference at the 16th International Congress on Genetics by announcing that he was leaving Canada to join the Department of Genetics and the Beckman Center for Molecular and Genetic Medicine headed by Paul Berg at Stanford University. He gave as his reason a lack of resources for basic research at his university and in Canada generally, and the low priority assigned to it. He noted that the reason for his departure was not just a matter of money, saying: “I have all the grant money I could ever want.” As the founder of the Medical Genetics Department of which he was a member, I was asked by the press for a reaction, and I gave it frankly. I told The Globe and Mail in Toronto that it was very depressing and that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies